| Immune Checkpoint Inhibitor studied in …STUDIED_INderived32 of 32show fewer |
|---|
| → studied in | NCT07572864Phase 2 · recruiting Neoadjuvant ICI and Mitochondrial Vaccine for Resectable HNSCC · 32 trials list this drug (18 active) | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07759856Phase 2 · recruiting NK Cells Plus ICI for SCLC Maintenance · 32 trials list this drug (18 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04913311recruiting Predictive Biomarkers for Pneumonitis After Chemoradiotherapy and Immunotherapy in Patients With Non-small Cell Lung Cancer · 32 trials list this drug (18 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07405086Phase 4 · recruiting Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study · 32 trials list this drug (18 active) | — | — | Malignant Solid Neoplasm,Melanoma,Malignant Lung Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06502691Phase 1/Phase 2 · recruiting [18F]FTT Positron Emission Tomography for the Measurement of PARP Tumor Expression in Patients With Metastatic Breast Cancer · 32 trials list this drug (18 active) | — | — | Breast Neoplasm,Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05846659Phase 2 · terminated Study of PULSAR-ICI +/- IMSA101 in Patients With Oligoprogressive Solid Tumor Malignancies · 32 trials list this drug (18 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05941741Phase 3 · recruiting IC Plus Low-dose Radiation Plus Cadonilimab in LANPC · 32 trials list this drug (18 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06819735Phase 1/Phase 2 · recruiting Study of DT-7012 as a Single Agent and in Combination With an Immune Checkpoint Inhibitor in Participants With Advanced Solid Tumors · 32 trials list this drug (18 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05522660Phase 3 · recruiting Immunotherapy or Targeted Therapy With or Without Stereotactic Radiosurgery for Patients With Brain Metastases From Melanoma or Non-small Cell Lung Cancer · 32 trials list this drug (18 active) | — | — | Melanoma,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03313804Phase 2 · completed Priming Immunotherapy in Advanced Disease With Radiation · 32 trials list this drug (18 active) | — | — | Head and Neck Squamous Cell Carcinoma,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07389876recruiting Albumin-bound Paclitaxel-based Second-line Treatment Regimens for Locally Advanced or Metastatic G/GEJ Adenocarcinoma · 32 trials list this drug (18 active) | — | — | Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06154538Phase 2 · recruiting Immune Checkpoint Inhibitors + Chemotherapy Versus Chemotherapy in the Neoadjuvant Treatment of Locally Advanced Colorectal Cancer · 32 trials list this drug (18 active) | — | — | Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05846646Phase 2 · terminated Study of PULSAR-ICI +/- IMSA101 in Patients With Oligometastatic NSCLC and RCC · 32 trials list this drug (18 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04954599Phase 1/Phase 2 · recruiting Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI · 32 trials list this drug (18 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07064668Phase 2 · not yet recruiting Tauroursodeoxycholic Acid Combined With PD-1/PD-L1 Immunotherapy in Advanced Hepatocellular Carcinoma: A Prospective Study · 32 trials list this drug (18 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06063681Phase 1 · recruiting A Study of SR-8541A (ENPPI Inhibitor) in Advanced/Metastatic Solid Tumors · 32 trials list this drug (18 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06730503recruiting Glycoprotein in Immunotherapy Response and Efficacy Prediction of Lung Cancer · 32 trials list this drug (18 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04020185Phase 1/Phase 2 · completed Safety and Efficacy Study of IMSA101 in Refractory Malignancies · 32 trials list this drug (18 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06026254Phase 1 · active not recruiting A Rollover Study for Subjects Who Completed Participation in IMSA101-101 Trial · 32 trials list this drug (18 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06388031Phase 2 · recruiting ICI Rechallenge for Advanced NSCLC With Long-Term Response to First-Line ICI · 32 trials list this drug (18 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05878977NA · recruiting Biomarkers in Immunotherapy of Melanoma · 32 trials list this drug (18 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04807114unknown A Single-cell Approach to Identify Biomarkers of Efficacy and Toxicity for ICI in NSCLC · 32 trials list this drug (18 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05059951recruiting Chemotherapy With or Without Immune Checkpoint Inhibitors for Lung Cancer · 32 trials list this drug (18 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03817736Phase 2 · completed Sequential TACE and SBRT Followed by ImmunoTherapy for Downstaging HCC for Hepatectomy · 32 trials list this drug (18 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05934214completed EXploring Immune-related Adverse Events of Immune checkpoinT Inhibitors Using VigiBase, the WHO Pharmacovigilance Database · 32 trials list this drug (18 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04944888Phase 1 · completed GSL Synthetase Inhibitor in Combination With Immune Checkpoint Inhibitor in Previously Treated Blood and Solid Tumor · 32 trials list this drug (18 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm,Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05913583unknown Correlation Between Pre-transplant ICI Exposure and Post-transplant Graft Rejection · 32 trials list this drug (18 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05609695unknown Immune Checkpoint Inhibitor Monotherapy or Combined With Molecular Targeted Drugs / Locoregional Therapy in the Treatment of Hepatocellular Carcinoma · 32 trials list this drug (18 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04137588unknown Efficacy and Safety of Use of Platinum Based Doublet Chemotherapy Plus Antiangiogenesis and Immune Checkpoint Inhibitors in Patients With Advanced Non-squamous Non-small Cell Lung Cancer · 32 trials list this drug (18 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04629027unknown Evaluation System for the Efficacy of Immunologic Checkpoint Inhibitors in NSCLC · 32 trials list this drug (18 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04419441unknown Immune Checkpoint Inhibitors and Radiotherapy in Relapsed/Refractory Hodgkin Lymphoma · 32 trials list this drug (18 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03492242completed Immune CHeckpoint Inhibitors Monitoring of Adverse Drug ReAction · 32 trials list this drug (18 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |